Development of New Preventive and Therapeutic Vaccines for Tuberculosis

Tuberculosis (TB) is a contagious disease that has been responsible for the death of one billion people in the last 200 years. Until now, the only vaccine approved for the prevention of TB is Bacillus Calmette-Guérin (BCG), which is prepared by attenuating . However, one of the limitations of BCG is...

Full description

Saved in:
Bibliographic Details
Published inImmune network Vol. 18; no. 2; pp. e17 - 19
Main Authors Kwon, Bo-Eun, Ahn, Jae-Hee, Min, Seunghwan, Kim, Hyeongseop, Seo, Jungheun, Yeo, Sang-Gu, Ko, Hyun-Jeong
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Association of Immunologists 01.04.2018
대한면역학회
Subjects
Review
면역학
Cell-based therapy
Cell-based vaccine
Adjuvant
Early secretory antigenic target-6
Tuberculosis
Viral vector
Online AccessGet full text
ISSN1598-2629
2092-6685
DOI10.4110/in.2018.18.e17

Cover

Abstract Tuberculosis (TB) is a contagious disease that has been responsible for the death of one billion people in the last 200 years. Until now, the only vaccine approved for the prevention of TB is Bacillus Calmette-Guérin (BCG), which is prepared by attenuating . However, one of the limitations of BCG is that its preventive effect against pulmonary TB varies from person to person. Therefore, there arises a need for a new TB vaccine to replace or supplement BCG. In this review, we have summarized the findings of current clinical trials on preventive and therapeutic TB vaccine candidates. In addition, we have discussed a novel vaccination approach using the cell-based vaccine presenting early secretory antigenic target-6 (ESAT-6), which is a potent immunogenic antigen. The role of ESAT-6 in hosts has also been described.
AbstractList Tuberculosis (TB) is a contagious disease that has been responsible for the death of one billion people in the last 200 years. Until now, the only vaccine approved for the prevention of TB is Bacillus Calmette-Guérin (BCG), which is prepared by attenuating . However, one of the limitations of BCG is that its preventive effect against pulmonary TB varies from person to person. Therefore, there arises a need for a new TB vaccine to replace or supplement BCG. In this review, we have summarized the findings of current clinical trials on preventive and therapeutic TB vaccine candidates. In addition, we have discussed a novel vaccination approach using the cell-based vaccine presenting early secretory antigenic target-6 (ESAT-6), which is a potent immunogenic antigen. The role of ESAT-6 in hosts has also been described.
Tuberculosis (TB) is a contagious disease that has been responsible for the death of one billion people in the last 200 years. Until now, the only vaccine approved for the prevention of TB is Bacillus Calmette-Guérin (BCG), which is prepared by attenuating Mycobacterium bovis. However, one of the limitations of BCG is that its preventive effect against pulmonary TB varies from person to person. Therefore, there arises a need for a new TB vaccine to replace or supplement BCG. In this review, we have summarized the findings of current clinical trials on preventive and therapeutic TB vaccine candidates. In addition, we have discussed a novel vaccination approach using the cell-based vaccine presenting early secretory antigenic target-6 (ESAT-6), which is a potent immunogenic antigen. The role of ESAT-6 in hosts has also been described.Tuberculosis (TB) is a contagious disease that has been responsible for the death of one billion people in the last 200 years. Until now, the only vaccine approved for the prevention of TB is Bacillus Calmette-Guérin (BCG), which is prepared by attenuating Mycobacterium bovis. However, one of the limitations of BCG is that its preventive effect against pulmonary TB varies from person to person. Therefore, there arises a need for a new TB vaccine to replace or supplement BCG. In this review, we have summarized the findings of current clinical trials on preventive and therapeutic TB vaccine candidates. In addition, we have discussed a novel vaccination approach using the cell-based vaccine presenting early secretory antigenic target-6 (ESAT-6), which is a potent immunogenic antigen. The role of ESAT-6 in hosts has also been described.
Tuberculosis (TB) is a contagious disease that has been responsible for the death of one billion people in the last 200 years. Until now, the only vaccine approved for the prevention of TB is Bacillus Calmette-Guérin (BCG), which is prepared by attenuating Mycobacterium bovis. However, one of the limitations of BCG is that its preventive effect against pulmonary TB varies from person to person. Therefore, there arises a need for a new TB vaccine to replace or supplement BCG. In this review, we have summarized the findings of current clinical trials on preventive and therapeutic TB vaccine candidates. In addition, we have discussed a novel vaccination approach using the cell-based vaccine presenting early secretory antigenic target-6 (ESAT-6), which is a potent immunogenic antigen. The role of ESAT-6 in hosts has also been described. KCI Citation Count: 3
Tuberculosis (TB) is a contagious disease that has been responsible for the death of one billion people in the last 200 years. Until now, the only vaccine approved for the prevention of TB is Bacillus Calmette-Guérin (BCG), which is prepared by attenuating Mycobacterium bovis . However, one of the limitations of BCG is that its preventive effect against pulmonary TB varies from person to person. Therefore, there arises a need for a new TB vaccine to replace or supplement BCG. In this review, we have summarized the findings of current clinical trials on preventive and therapeutic TB vaccine candidates. In addition, we have discussed a novel vaccination approach using the cell-based vaccine presenting early secretory antigenic target-6 (ESAT-6), which is a potent immunogenic antigen. The role of ESAT-6 in hosts has also been described.
Author Seo, Jungheun
Kim, Hyeongseop
Min, Seunghwan
Kwon, Bo-Eun
Yeo, Sang-Gu
Ahn, Jae-Hee
Ko, Hyun-Jeong
AuthorAffiliation 1 Laboratory of Microbiology and Immunology, Kangwon National University, College of Pharmacy, Chuncheon 24341, Korea
2 Division of Vaccine Research, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Korea
AuthorAffiliation_xml – name: 1 Laboratory of Microbiology and Immunology, Kangwon National University, College of Pharmacy, Chuncheon 24341, Korea
– name: 2 Division of Vaccine Research, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Korea
Author_xml – sequence: 1
  givenname: Bo-Eun
  surname: Kwon
  fullname: Kwon, Bo-Eun
  organization: Laboratory of Microbiology and Immunology, Kangwon National University, College of Pharmacy, Chuncheon 24341, Korea
– sequence: 2
  givenname: Jae-Hee
  surname: Ahn
  fullname: Ahn, Jae-Hee
  organization: Laboratory of Microbiology and Immunology, Kangwon National University, College of Pharmacy, Chuncheon 24341, Korea
– sequence: 3
  givenname: Seunghwan
  surname: Min
  fullname: Min, Seunghwan
  organization: Laboratory of Microbiology and Immunology, Kangwon National University, College of Pharmacy, Chuncheon 24341, Korea
– sequence: 4
  givenname: Hyeongseop
  surname: Kim
  fullname: Kim, Hyeongseop
  organization: Laboratory of Microbiology and Immunology, Kangwon National University, College of Pharmacy, Chuncheon 24341, Korea
– sequence: 5
  givenname: Jungheun
  surname: Seo
  fullname: Seo, Jungheun
  organization: Laboratory of Microbiology and Immunology, Kangwon National University, College of Pharmacy, Chuncheon 24341, Korea
– sequence: 6
  givenname: Sang-Gu
  surname: Yeo
  fullname: Yeo, Sang-Gu
  organization: Division of Vaccine Research, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju 28159, Korea
– sequence: 7
  givenname: Hyun-Jeong
  surname: Ko
  fullname: Ko, Hyun-Jeong
  organization: Laboratory of Microbiology and Immunology, Kangwon National University, College of Pharmacy, Chuncheon 24341, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29732235$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002342040$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kd1LHDEUxUNR6rrtax9lHvVh1nxMJpMXQfzqgrSlbPsaMpkbTZ1N1mRmxf_erGtFCyUHLiS_c26Su492fPCA0BeCZxUh-Nj5GcWkmWUBER_QhGJJy7pu-A6aEC6bktZU7qH9lP5gXFdM8I9oj0rBKGV8gq7OYQ19WC3BD0WwxTd4KH7EvOcHt4ZC-65Y3ELUKxgHZ4rf2hjnIRU2xGIxthDN2Ifk0ie0a3Wf4PNLnaJflxeLs6_l9fer-dnpdWkqWg2lkU2ja8qx4J3JIh1w22Cr2xYbQYS0mMnOWMOxllxraDmnLZbM1nmBZFN0tM310ao741TQ7rneBHUX1enPxVwxRppasMyebNnV2C6hM_lNUfdqFd1Sx8dn5_sT725zzlpxSZuK1Dng8CUghvsR0qCWLhnoe-0hjElRzLjAgsgNevC212uTvz-dgdkWMDGkFMG-IgSrzSiV82ozSpWVR5kN1T8G4wY9uLC5q-v_Z3sC9YqkAA
CitedBy_id crossref_primary_10_1016_j_micpath_2018_09_009
crossref_primary_10_1128_AAC_01727_19
crossref_primary_10_3390_cells10010078
crossref_primary_10_3390_pathogens11101153
crossref_primary_10_1089_jir_2024_0030
crossref_primary_10_3389_fimmu_2021_632304
crossref_primary_10_1177_11769351221150772
crossref_primary_10_3389_fcimb_2019_00299
crossref_primary_10_1371_journal_pone_0228381
crossref_primary_10_1016_j_vaccine_2024_07_052
crossref_primary_10_3389_fimmu_2019_02542
crossref_primary_10_3390_vaccines8010067
crossref_primary_10_1016_j_micres_2022_127153
crossref_primary_10_1002_jcla_25122
crossref_primary_10_1155_2019_8295261
crossref_primary_10_2174_0929867326666181126112124
crossref_primary_10_1016_j_heliyon_2024_e26193
crossref_primary_10_1016_j_phymed_2021_153649
crossref_primary_10_3389_fimmu_2023_1138818
crossref_primary_10_3390_pharmaceutics16070857
Cites_doi 10.1097/QAD.0b013e3283350f1b
10.1038/srep45969
10.1371/journal.pone.0020302
10.1371/journal.pone.0005856
10.1038/cddis.2014.394
10.1001/jama.300.4.423
10.1016/j.vaccine.2014.10.036
10.1111/sji.12465
10.1128/JB.00469-07
10.1017/S0950268897007917
10.1371/journal.ppat.1004770
10.1186/1476-8518-9-3
10.1016/j.chom.2017.05.012
10.1016/j.jim.2017.10.005
10.3389/fimmu.2017.01147
10.4049/jimmunol.1600817
10.1074/jbc.M117.775205
10.1016/j.vaccine.2012.12.053
10.1093/trstmh/trw016
10.1146/annurev.immunol.18.1.927
10.1016/j.vaccine.2016.11.023
10.1016/j.cell.2012.06.040
10.1371/journal.pone.0012320
10.1128/IAI.55.7.1641-1646.1987
10.1073/pnas.1635213100
10.1093/cid/cit790
10.1016/j.vaccine.2012.07.061
10.1038/ncomms15776
10.1093/infdis/jis425
10.1186/s12941-016-0156-y
10.1016/j.tube.2017.02.003
10.1158/0008-5472.CAN-06-0889
10.1186/1471-2458-9-450
10.1016/j.vaccine.2009.10.114
10.1128/IAI.68.2.791-795.2000
10.1371/journal.ppat.1004446
10.1128/mBio.00679-16
10.1073/pnas.1707792114
10.1016/j.chom.2015.05.003
10.1038/502S2a
10.1371/journal.pone.0114602
10.4049/jimmunol.177.10.6747
10.1016/j.vaccine.2015.03.056
10.1016/j.chom.2011.09.010
10.1016/j.chom.2015.05.005
10.1016/j.vaccine.2015.06.051
10.1371/journal.ppat.0030110
10.1182/blood-2006-12-061309
10.1183/13993003.01891-2015
10.1016/j.tube.2016.07.005
10.1128/CVI.00439-16
10.1016/j.chom.2008.01.002
10.1016/j.vaccine.2013.07.051
10.1038/srep39475
10.1086/314072
10.1126/science.290.5493.992
10.1111/j.1365-3083.2011.02655.x
10.4161/auto.20881
10.1001/jama.286.14.1740
10.1016/S0140-6736(10)60483-7
10.1128/mBio.01370-16
10.1093/intimm/dxs062
10.3892/mmr.2016.5364
10.1016/j.toxicon.2015.10.003
10.1016/j.chom.2015.05.004
10.1126/scitranslmed.3009885
10.1371/journal.pone.0061135
10.1128/IAI.00614-08
10.1002/ijc.23444
10.1158/0008-5472.CAN-08-1721
10.1126/scitranslmed.3006843
10.4049/jimmunol.1201538
10.1016/j.vaccine.2015.08.033
10.1016/j.bbrc.2016.06.042
10.1016/j.jconrel.2015.05.004
10.3389/fmed.2017.00171
10.1093/femspd/ftw016
10.1016/S0140-6736(13)60177-4
10.1016/S2213-2600(14)70033-5
10.1371/journal.pone.0039909
10.1164/rccm.201603-0654OC
10.1172/JCI24617
10.1016/j.vaccine.2016.03.029
ContentType Journal Article
Copyright Copyright © 2018. The Korean Association of Immunologists 2018 The Korean Association of Immunologists
Copyright_xml – notice: Copyright © 2018. The Korean Association of Immunologists 2018 The Korean Association of Immunologists
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.4110/in.2018.18.e17
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2092-6685
EndPage 19
ExternalDocumentID oai_kci_go_kr_ARTI_3318673
PMC5928416
29732235
10_4110_in_2018_18_e17
Genre Journal Article
Review
GrantInformation_xml – fundername: ;
  grantid: HI15C0450
GroupedDBID 5-W
53G
8JR
8XY
9ZL
AAYXX
ACYCR
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DBRKI
DIK
E3Z
EF.
F5P
GW5
HYE
KQ8
KVFHK
M48
MZR
O5R
O5S
OK1
PGMZT
RPM
TDB
ZZE
.UV
M~E
NPM
7X8
5PM
ID FETCH-LOGICAL-c424t-c988a625075dc5dc1de5f80fabb0c7179f039dcfc50a95aaeb552b093f6f6fe93
IEDL.DBID M48
ISSN 1598-2629
IngestDate Sun Mar 09 07:50:36 EDT 2025
Thu Aug 21 14:12:06 EDT 2025
Thu Jul 10 18:14:37 EDT 2025
Wed Feb 19 02:41:39 EST 2025
Thu Apr 24 23:10:07 EDT 2025
Tue Jul 01 00:45:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Cell-based therapy
Cell-based vaccine
Adjuvant
Early secretory antigenic target-6
Tuberculosis
Viral vector
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c424t-c988a625075dc5dc1de5f80fabb0c7179f039dcfc50a95aaeb552b093f6f6fe93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Bo-Eun Kwon and Jae-Hee Ahn contributed equally to this work.
https://doi.org/10.4110/in.2018.18.e17
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4110/in.2018.18.e17
PMID 29732235
PQID 2035707196
PQPubID 23479
PageCount 19
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_3318673
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5928416
proquest_miscellaneous_2035707196
pubmed_primary_29732235
crossref_primary_10_4110_in_2018_18_e17
crossref_citationtrail_10_4110_in_2018_18_e17
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-04-01
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Immune network
PublicationTitleAlternate Immune Netw
PublicationYear 2018
Publisher The Korean Association of Immunologists
대한면역학회
Publisher_xml – name: The Korean Association of Immunologists
– name: 대한면역학회
References Reither (10.4110/in.2018.18.e17_ref32) 2014; 9
Bruns (10.4110/in.2018.18.e17_ref11) 2012; 189
Kim (10.4110/in.2018.18.e17_ref63) 2008; 122
Lönnroth (10.4110/in.2018.18.e17_ref4) 2010; 375
Xing (10.4110/in.2018.18.e17_ref42) 2009; 4
Francis (10.4110/in.2018.18.e17_ref69) 2014; 5
Agyeman (10.4110/in.2018.18.e17_ref10) 2016; 15
Verreck (10.4110/in.2018.18.e17_ref15) 2017; 104
Luabeya (10.4110/in.2018.18.e17_ref34) 2015; 33
Köster (10.4110/in.2018.18.e17_ref82) 2017; 114
Mearns (10.4110/in.2018.18.e17_ref31) 2017; 35
von Reyn (10.4110/in.2018.18.e17_ref45) 2010; 24
Nieuwenhuizen (10.4110/in.2018.18.e17_ref19) 2017; 8
Dong (10.4110/in.2018.18.e17_ref72) 2016; 477
Grode (10.4110/in.2018.18.e17_ref21) 2005; 115
Gengenbacher (10.4110/in.2018.18.e17_ref54) 2016; 7
Sreejit (10.4110/in.2018.18.e17_ref76) 2014; 10
Saiga (10.4110/in.2018.18.e17_ref84) 2012; 24
Feng (10.4110/in.2018.18.e17_ref59) 2013; 8
Butov (10.4110/in.2018.18.e17_ref46) 2011; 9
Esparza-González (10.4110/in.2018.18.e17_ref57) 2012; 75
Ruhwald (10.4110/in.2018.18.e17_ref85) 2017; 7
Tameris (10.4110/in.2018.18.e17_ref40) 2013; 381
Hsu (10.4110/in.2018.18.e17_ref73) 2003; 100
Havlir (10.4110/in.2018.18.e17_ref3) 2008; 300
Gurunathan (10.4110/in.2018.18.e17_ref58) 2000; 18
de Jonge (10.4110/in.2018.18.e17_ref67) 2007; 189
Skeiky (10.4110/in.2018.18.e17_ref36) 2010; 28
Smaill (10.4110/in.2018.18.e17_ref43) 2013; 5
Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group (10.4110/in.2018.18.e17_ref29) 2015; 33
Paulson (10.4110/in.2018.18.e17_ref1) 2013; 502
Decatur (10.4110/in.2018.18.e17_ref22) 2000; 290
Singhal (10.4110/in.2018.18.e17_ref14) 2014; 6
Loxton (10.4110/in.2018.18.e17_ref25) 2017; 24
Cha (10.4110/in.2018.18.e17_ref37) 2016; 34
Watson (10.4110/in.2018.18.e17_ref78) 2015; 17
Fletcher (10.4110/in.2018.18.e17_ref24) 2016; 110
He (10.4110/in.2018.18.e17_ref48) 2018; 452
Liang (10.4110/in.2018.18.e17_ref60) 2016; 14
Brandt (10.4110/in.2018.18.e17_ref56) 2000; 68
Rehm (10.4110/in.2018.18.e17_ref5) 2009; 9
van Dissel (10.4110/in.2018.18.e17_ref33) 2014; 32
Grode (10.4110/in.2018.18.e17_ref18) 2013; 31
Moguche (10.4110/in.2018.18.e17_ref55) 2017; 21
McElvania Tekippe (10.4110/in.2018.18.e17_ref83) 2010; 5
Moliva (10.4110/in.2018.18.e17_ref23) 2015; 33
Méndez-Samperio (10.4110/in.2018.18.e17_ref44) 2016; 84
Napier (10.4110/in.2018.18.e17_ref12) 2015; 11
Geoffroy (10.4110/in.2018.18.e17_ref20) 1987; 55
Smith (10.4110/in.2018.18.e17_ref74) 2008; 76
Collins (10.4110/in.2018.18.e17_ref80) 2015; 17
Gillard (10.4110/in.2018.18.e17_ref51) 2016; 100
Hong (10.4110/in.2018.18.e17_ref64) 2006; 177
Chung (10.4110/in.2018.18.e17_ref65) 2007; 110
World Health Organization (10.4110/in.2018.18.e17_ref2) 2016
Coler (10.4110/in.2018.18.e17_ref38) 2013; 207
Dockrell (10.4110/in.2018.18.e17_ref39) 2016; 74
Rose (10.4110/in.2018.18.e17_ref52) 2015; 210
Velmurugan (10.4110/in.2018.18.e17_ref53) 2007; 3
Seghatoleslam (10.4110/in.2018.18.e17_ref68) 2016; 41
Mazurek (10.4110/in.2018.18.e17_ref7) 2001; 286
Napier (10.4110/in.2018.18.e17_ref13) 2011; 10
Detienne (10.4110/in.2018.18.e17_ref50) 2016; 6
Arbues (10.4110/in.2018.18.e17_ref30) 2013; 31
Peng (10.4110/in.2018.18.e17_ref75) 2016; 116
Sengupta (10.4110/in.2018.18.e17_ref77) 2017; 292
Gupta (10.4110/in.2018.18.e17_ref47) 2012; 30
Lee (10.4110/in.2018.18.e17_ref28) 2008; 3
Kaufmann (10.4110/in.2018.18.e17_ref27) 2014; 2
Wassermann (10.4110/in.2018.18.e17_ref81) 2015; 17
Billeskov (10.4110/in.2018.18.e17_ref35) 2012; 7
Welin (10.4110/in.2018.18.e17_ref70) 2011; 6
van Zyl-Smit (10.4110/in.2018.18.e17_ref41) 2017; 195
Vynnycky (10.4110/in.2018.18.e17_ref6) 1997; 119
Kolloli (10.4110/in.2018.18.e17_ref8) 2017; 4
Pontali (10.4110/in.2018.18.e17_ref9) 2016; 47
Romagnoli (10.4110/in.2018.18.e17_ref71) 2012; 8
Watson (10.4110/in.2018.18.e17_ref79) 2012; 150
Fletcher (10.4110/in.2018.18.e17_ref26) 2016; 7
Chung (10.4110/in.2018.18.e17_ref62) 2006; 66
Seo (10.4110/in.2018.18.e17_ref61) 2017; 8
Hong (10.4110/in.2018.18.e17_ref66) 2009; 69
Mangtani (10.4110/in.2018.18.e17_ref17) 2014; 58
Brewer (10.4110/in.2018.18.e17_ref16) 2000; 31
Neeland (10.4110/in.2018.18.e17_ref49) 2016; 197
References_xml – volume: 24
  start-page: 675
  year: 2010
  ident: 10.4110/in.2018.18.e17_ref45
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e3283350f1b
– volume-title: Global Tuberculosis Report 2016
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref2
– volume: 7
  start-page: 45969
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref85
  publication-title: Sci Rep
  doi: 10.1038/srep45969
– volume: 6
  start-page: e20302
  year: 2011
  ident: 10.4110/in.2018.18.e17_ref70
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0020302
– volume: 4
  start-page: e5856
  year: 2009
  ident: 10.4110/in.2018.18.e17_ref42
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0005856
– volume: 5
  start-page: e1474
  year: 2014
  ident: 10.4110/in.2018.18.e17_ref69
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2014.394
– volume: 300
  start-page: 423
  year: 2008
  ident: 10.4110/in.2018.18.e17_ref3
  publication-title: JAMA
  doi: 10.1001/jama.300.4.423
– volume: 32
  start-page: 7098
  year: 2014
  ident: 10.4110/in.2018.18.e17_ref33
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2014.10.036
– volume: 84
  start-page: 204
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref44
  publication-title: Scand J Immunol
  doi: 10.1111/sji.12465
– volume: 189
  start-page: 6028
  year: 2007
  ident: 10.4110/in.2018.18.e17_ref67
  publication-title: J Bacteriol
  doi: 10.1128/JB.00469-07
– volume: 119
  start-page: 183
  year: 1997
  ident: 10.4110/in.2018.18.e17_ref6
  publication-title: Epidemiol Infect
  doi: 10.1017/S0950268897007917
– volume: 11
  start-page: e1004770
  year: 2015
  ident: 10.4110/in.2018.18.e17_ref12
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004770
– volume: 9
  start-page: 3
  year: 2011
  ident: 10.4110/in.2018.18.e17_ref46
  publication-title: J Immune Based Ther Vaccines
  doi: 10.1186/1476-8518-9-3
– volume: 21
  start-page: 695
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref55
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2017.05.012
– volume: 452
  start-page: 39
  year: 2018
  ident: 10.4110/in.2018.18.e17_ref48
  publication-title: J Immunol Methods
  doi: 10.1016/j.jim.2017.10.005
– volume: 8
  start-page: 1147
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref19
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.01147
– volume: 197
  start-page: 2704
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref49
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1600817
– volume: 292
  start-page: 6855
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref77
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M117.775205
– volume: 31
  start-page: 1340
  year: 2013
  ident: 10.4110/in.2018.18.e17_ref18
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2012.12.053
– volume: 110
  start-page: 212
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref24
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1093/trstmh/trw016
– volume: 18
  start-page: 927
  year: 2000
  ident: 10.4110/in.2018.18.e17_ref58
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.18.1.927
– volume: 35
  start-page: 132
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref31
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.11.023
– volume: 150
  start-page: 803
  year: 2012
  ident: 10.4110/in.2018.18.e17_ref79
  publication-title: Cell
  doi: 10.1016/j.cell.2012.06.040
– volume: 5
  start-page: e12320
  year: 2010
  ident: 10.4110/in.2018.18.e17_ref83
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0012320
– volume: 55
  start-page: 1641
  year: 1987
  ident: 10.4110/in.2018.18.e17_ref20
  publication-title: Infect Immun
  doi: 10.1128/IAI.55.7.1641-1646.1987
– volume: 41
  start-page: 296
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref68
  publication-title: Iran J Med Sci
– volume: 100
  start-page: 12420
  year: 2003
  ident: 10.4110/in.2018.18.e17_ref73
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1635213100
– volume: 58
  start-page: 470
  year: 2014
  ident: 10.4110/in.2018.18.e17_ref17
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cit790
– volume: 30
  start-page: 6198
  year: 2012
  ident: 10.4110/in.2018.18.e17_ref47
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2012.07.061
– volume: 8
  start-page: 15776
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref61
  publication-title: Nat Commun
  doi: 10.1038/ncomms15776
– volume: 207
  start-page: 1242
  year: 2013
  ident: 10.4110/in.2018.18.e17_ref38
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jis425
– volume: 15
  start-page: 41
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref10
  publication-title: Ann Clin Microbiol Antimicrob
  doi: 10.1186/s12941-016-0156-y
– volume: 104
  start-page: 46
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref15
  publication-title: Tuberculosis (Edinb)
  doi: 10.1016/j.tube.2017.02.003
– volume: 66
  start-page: 6843
  year: 2006
  ident: 10.4110/in.2018.18.e17_ref62
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-0889
– volume: 9
  start-page: 450
  year: 2009
  ident: 10.4110/in.2018.18.e17_ref5
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-9-450
– volume: 28
  start-page: 1084
  year: 2010
  ident: 10.4110/in.2018.18.e17_ref36
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.10.114
– volume: 68
  start-page: 791
  year: 2000
  ident: 10.4110/in.2018.18.e17_ref56
  publication-title: Infect Immun
  doi: 10.1128/IAI.68.2.791-795.2000
– volume: 10
  start-page: e1004446
  year: 2014
  ident: 10.4110/in.2018.18.e17_ref76
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004446
– volume: 7
  start-page: e00679
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref54
  publication-title: MBio
  doi: 10.1128/mBio.00679-16
– volume: 114
  start-page: E8711
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref82
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1707792114
– volume: 17
  start-page: 799
  year: 2015
  ident: 10.4110/in.2018.18.e17_ref81
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2015.05.003
– volume: 502
  start-page: S2
  year: 2013
  ident: 10.4110/in.2018.18.e17_ref1
  publication-title: Nature
  doi: 10.1038/502S2a
– volume: 9
  start-page: e114602
  year: 2014
  ident: 10.4110/in.2018.18.e17_ref32
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0114602
– volume: 177
  start-page: 6747
  year: 2006
  ident: 10.4110/in.2018.18.e17_ref64
  publication-title: J Immunol
  doi: 10.4049/jimmunol.177.10.6747
– volume: 33
  start-page: 3047
  year: 2015
  ident: 10.4110/in.2018.18.e17_ref29
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.03.056
– volume: 10
  start-page: 475
  year: 2011
  ident: 10.4110/in.2018.18.e17_ref13
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2011.09.010
– volume: 17
  start-page: 820
  year: 2015
  ident: 10.4110/in.2018.18.e17_ref80
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2015.05.005
– volume: 33
  start-page: 4130
  year: 2015
  ident: 10.4110/in.2018.18.e17_ref34
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.06.051
– volume: 3
  start-page: e110
  year: 2007
  ident: 10.4110/in.2018.18.e17_ref53
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.0030110
– volume: 110
  start-page: 2013
  year: 2007
  ident: 10.4110/in.2018.18.e17_ref65
  publication-title: Blood
  doi: 10.1182/blood-2006-12-061309
– volume: 47
  start-page: 394
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref9
  publication-title: Eur Respir J
  doi: 10.1183/13993003.01891-2015
– volume: 100
  start-page: 118
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref51
  publication-title: Tuberculosis (Edinb)
  doi: 10.1016/j.tube.2016.07.005
– volume: 24
  start-page: e00439
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref25
  publication-title: Clin Vaccine Immunol
  doi: 10.1128/CVI.00439-16
– volume: 3
  start-page: 97
  year: 2008
  ident: 10.4110/in.2018.18.e17_ref28
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2008.01.002
– volume: 31
  start-page: 4867
  year: 2013
  ident: 10.4110/in.2018.18.e17_ref30
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2013.07.051
– volume: 6
  start-page: 39475
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref50
  publication-title: Sci Rep
  doi: 10.1038/srep39475
– volume: 31
  start-page: S64
  issue: Suppl 3
  year: 2000
  ident: 10.4110/in.2018.18.e17_ref16
  publication-title: Clin Infect Dis
  doi: 10.1086/314072
– volume: 290
  start-page: 992
  year: 2000
  ident: 10.4110/in.2018.18.e17_ref22
  publication-title: Science
  doi: 10.1126/science.290.5493.992
– volume: 75
  start-page: 259
  year: 2012
  ident: 10.4110/in.2018.18.e17_ref57
  publication-title: Scand J Immunol
  doi: 10.1111/j.1365-3083.2011.02655.x
– volume: 8
  start-page: 1357
  year: 2012
  ident: 10.4110/in.2018.18.e17_ref71
  publication-title: Autophagy
  doi: 10.4161/auto.20881
– volume: 286
  start-page: 1740
  year: 2001
  ident: 10.4110/in.2018.18.e17_ref7
  publication-title: JAMA
  doi: 10.1001/jama.286.14.1740
– volume: 375
  start-page: 1814
  year: 2010
  ident: 10.4110/in.2018.18.e17_ref4
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60483-7
– volume: 7
  start-page: e01370
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref26
  publication-title: MBio
  doi: 10.1128/mBio.01370-16
– volume: 24
  start-page: 637
  year: 2012
  ident: 10.4110/in.2018.18.e17_ref84
  publication-title: Int Immunol
  doi: 10.1093/intimm/dxs062
– volume: 14
  start-page: 1146
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref60
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2016.5364
– volume: 116
  start-page: 29
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref75
  publication-title: Toxicon
  doi: 10.1016/j.toxicon.2015.10.003
– volume: 17
  start-page: 811
  year: 2015
  ident: 10.4110/in.2018.18.e17_ref78
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2015.05.004
– volume: 6
  start-page: 263ra159
  year: 2014
  ident: 10.4110/in.2018.18.e17_ref14
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3009885
– volume: 8
  start-page: e61135
  year: 2013
  ident: 10.4110/in.2018.18.e17_ref59
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0061135
– volume: 76
  start-page: 5478
  year: 2008
  ident: 10.4110/in.2018.18.e17_ref74
  publication-title: Infect Immun
  doi: 10.1128/IAI.00614-08
– volume: 122
  start-page: 2774
  year: 2008
  ident: 10.4110/in.2018.18.e17_ref63
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23444
– volume: 69
  start-page: 4301
  year: 2009
  ident: 10.4110/in.2018.18.e17_ref66
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-1721
– volume: 5
  start-page: 205ra134
  year: 2013
  ident: 10.4110/in.2018.18.e17_ref43
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3006843
– volume: 189
  start-page: 4069
  year: 2012
  ident: 10.4110/in.2018.18.e17_ref11
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1201538
– volume: 33
  start-page: 5035
  year: 2015
  ident: 10.4110/in.2018.18.e17_ref23
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.08.033
– volume: 477
  start-page: 195
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref72
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2016.06.042
– volume: 210
  start-page: 48
  year: 2015
  ident: 10.4110/in.2018.18.e17_ref52
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2015.05.004
– volume: 4
  start-page: 171
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref8
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2017.00171
– volume: 74
  start-page: ftw016
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref39
  publication-title: Pathog Dis
  doi: 10.1093/femspd/ftw016
– volume: 381
  start-page: 1021
  year: 2013
  ident: 10.4110/in.2018.18.e17_ref40
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)60177-4
– volume: 2
  start-page: 301
  year: 2014
  ident: 10.4110/in.2018.18.e17_ref27
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(14)70033-5
– volume: 7
  start-page: e39909
  year: 2012
  ident: 10.4110/in.2018.18.e17_ref35
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0039909
– volume: 195
  start-page: 1171
  year: 2017
  ident: 10.4110/in.2018.18.e17_ref41
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201603-0654OC
– volume: 115
  start-page: 2472
  year: 2005
  ident: 10.4110/in.2018.18.e17_ref21
  publication-title: J Clin Invest
  doi: 10.1172/JCI24617
– volume: 34
  start-page: 2179
  year: 2016
  ident: 10.4110/in.2018.18.e17_ref37
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.03.029
SSID ssj0064375
Score 2.1585913
SecondaryResourceType review_article
Snippet Tuberculosis (TB) is a contagious disease that has been responsible for the death of one billion people in the last 200 years. Until now, the only vaccine...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e17
SubjectTerms Review
면역학
Title Development of New Preventive and Therapeutic Vaccines for Tuberculosis
URI https://www.ncbi.nlm.nih.gov/pubmed/29732235
https://www.proquest.com/docview/2035707196
https://pubmed.ncbi.nlm.nih.gov/PMC5928416
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002342040
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Immune Network, 2018, 18(2), , pp.1-19
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB-8E8EX8dv6cUQRfOraj6RtnkTE8xTOp125t5CkE6_c0mq7K95_78x2d-9WVpAG-tC0oTNJ5zeZ6W8AXpNFCrlNMNZB-lgGWopV5kJcaUyL2vosDbzfcfq1OJnJL2fq7Cr_aS3AYa9rx_WkZv188vvn5Tta8IRfJ5Ks19uGeUzTakIN0_IAbpJVKniGn8ptRIHjU2rFnappZhSZHgkc99y_Y6AO2j7sw55_p1Bes0nHd-HOGkyK96P278ENbO_DrbG85OUD-HQtI0h0QdAHTWwom36hsG0tple_X4lv1nOUfRCEY8V06bD3y3k3NMNDmB1_nH44ideFE2IvM7mIva4qS44NwYHaU0trVKFKgnUu8eS_6ZDkuvbBq8RqZS06pTKX6DwUdKDOH8Fh27X4BESCjKp8pkvnZKVLi4iyQKzq1JJzkUYQb6Rl_JpVnItbzA15Fyxd07SGpWuokXQjeLPt_2Pk0_hnz1ckfHPhG8MU2Hz-3pmL3hDQ_2zynJn48ghebnRjaF1wsMO22C0HelKuSsJPuojg8air7YBcr4tgkYqg3NHitgMPuHulbc5X3NtKZxyoffof4z6D2_w6Y5rPczhc9Et8QQhm4Y5WU_NotbX0B3QB8Mo
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+New+Preventive+and+Therapeutic+Vaccines+for+Tuberculosis&rft.jtitle=Immune+network&rft.au=Kwon%2C+Bo-Eun&rft.au=Ahn%2C+Jae-Hee&rft.au=Min%2C+Seunghwan&rft.au=Kim%2C+Hyeongseop&rft.date=2018-04-01&rft.issn=1598-2629&rft.volume=18&rft.issue=2&rft.spage=e17&rft_id=info:doi/10.4110%2Fin.2018.18.e17&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2629&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2629&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2629&client=summon